Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Cells from concentrated growth factor can become different cell types.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

MPZL3 is crucial for seborrheic dermatitis development.

γδ T cells are crucial for early wound healing after a skin virus infection.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Disrupting a specific protein's function in hair follicle stem cells triggers their activation and a self-healing process.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Desmoglein 3 is important for keeping hair follicle stem cells inactive and maintaining their special properties.

B cells can both help and hinder the body's defense against melanoma.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

BTNL2 helps protect hair follicles from immune attacks.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Certain genes influence immunoglobulin levels in Chinese Holstein cows, which can improve calf health.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.